NORMOTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN PERITONEAL METASTASES FROM COLORECTAL CANCER – FEASIBILITY STUDY (NIPEC-OXA)

ABSTRACT: Primary objectives: Analysis of chemotherapy toxicity given through i.p. during NIPEC-OXA throughout the entire treatment period, including a 3-month follow-up. Primary endpoints: Adverse Event meassured by CTCAE 5.0

DISEASE(S): Colorectal Cancer Metastatic,Metastases From Colorectal Cancer

PROVIDER: 2540825 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR